COVID-19 rapid guideline: children and young people who are immunocompromised- updated guideline (NG174)

Immunosuppressant medicines have been added to recommendation 1.4 because these should be reviewed if a child or young person may have COVID-19 or there are medical concerns. Recommendation 1.7 has been aligned with UK government guidance for young people on shielding.


National Institute for Health and Care Excellence